Revolution Medicines, Inc. is 4.5x more valuable than Vaxcyte, Inc. by market capitalization ($30.74 B vs $6.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PCVX | RVMD |
|---|---|---|
| Market cap | $6.81 B | $30.74 B |
| US-listed rank | #1179 | #453 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$766.63K | -$1.13B |
| SEC filings | 690 | 782 |
Revolution Medicines, Inc. is 4.5x more valuable than Vaxcyte, Inc. by market capitalization ($30.74 B vs $6.81 B).
Full pages: Vaxcyte, Inc. and Revolution Medicines, Inc., or browse the full rankings.